Clearance Summary
URIC ACID (URICASE) METHOD-II received FDA 510(k) clearance under submission number K863287, sponsored by Catachem, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1986-09-29.
- Submission: K863287
- Applicant / Sponsor: Catachem, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1775
- Decision date: 1986-09-29
Classification & Regulation
This clearance is catalogued under FDA product code JHC and 21 CFR 862.1775, within the Clinical Chemistry review panel as a Class I device.